Optic Pathway Glioma - 25 Studies Found
Terminated |
: 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas :
|
Recruiting |
: Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors :
|
Terminated |
: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia :
|
Completed |
: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma :
|
Completed |
: Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment :
|
Recruiting |
: Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors :
|
Active, not recruiting |
: Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor :
|
Completed |
: AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors :
|
Completed |
: Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas :
|
Completed |
: Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas :
: |